This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Are you wondering what the difference is between medical-grade skincare products and over-the-counter products? In this blog post, we will discuss the key differences between medical-grade skincare and over-the-counter products - so you can decide which route is best for you. What is medical-grade skincare?
L+A is proud to welcome Dr. Vincent Wong to our Editorial Team as a Medical Contributor. He has authored a textbook on Aesthetic Medicine, published over 35 scientific papers, and serves as a Global Advisor for major pharmaceutical companies.
Novartis is the official first-in-category corporate pharmaceutical partner of the National Football League (NFL). “At the NFL, we’re always looking for new ways to provide the highest level of care to our players, including through collaboration with experts across the medical field.
young pharmaceuticals, global expansion, new global headquarters, John Kulesza, skin care products, skin care, business, business expansion, medical aesthetics, dermatologic products
Cyr, PhD, Senior Director of Medical Affairs at Regeneron Pharmaceuticals, received the best poster Akamai Award at the meeting. Dupilumab (Dupixent, Sanofi & Regeneron) may boost height in kids with severe atopic dermatitis (AD), according to a late-breaking abstract presented at Maui Derm Hawaii 2025.
We are proud to collaborate with DEBRA Research, whose vast experience in the pharmaceutical industry and commitment to advancing medical research are invaluable. At LEO Pharma, we build partnerships that help us stay on the lookout and contribute our expertise to the next advancements. Together, we can do so much more.
Pharmaceutical and Medical Advancements Ingredients that have been traditionally used for non-skincare purposes are now finding their way into the beauty industry. Even Botox, popular in the modern day for smoothing fine lines and plumping the skin, was first used as a treatment for Parkinson’s.
Reduced Inflammation : Compounds like oleocanthal mimic anti-inflammatory medications, offering natural pain relief. Current Pharmaceutical Design , 17(8), pp.754768. Bone Health : Olive oil helps improve calcium absorption, supporting bone densitya crucial factor for postmenopausal women. New England Journal of Medicine , 368(14), pp.12791290.
Phyllis Hsieh is the visionary behind Conrex Pharmaceutical Corp. Medical and spa skincare professionals must use specially formulated serums that are designed to work with nano infusion that deliver active ingredients deep into the skin. The Permeation Enhancement Technology is FDA-approved in pharmaceuticals.
More than 200 residents, medical students and Fellow members have committed to volunteer for MBWS outreach events at universities, hospitals, and community venues, with a planned distribution of 10,000 gift bags with tips for managing winter skin and free moisturizing products generously provided by campaign sponsor, Clinique.
Tildrakizumab-asmn (Ilumya, Sun Pharmaceutical Industries, Inc.) improves moderate-to-severe nail psoriasis, according to new research presented at the 2025American Academy of Dermatology(AAD) Annual Meeting in Orlando, FL. In addition, 29.4% in the placebo group.
LP-310, developed by Lipella Pharmaceuticals for the treatment of oral lichen planus (OLP), is currently in Phase 2 clinical trials. There are currently no drugs specifically approved for lichen planus and available treatments are primarily palliative. Similarly, Incyte and AFYX Therapeutics are developing new therapeutics for lichen planus.
Ligand Pharmaceuticals is launching Pelthos Therapeutics (Pelthos), a biopharmaceutical company, and has appointed Scott Plesha as Chief Executive Officer to accelerate the commercialization of berdazimer topical gel, 10.3% (Zelsuvmi) for the treatment of molluscum contagiosum. in September 2023.
Elyse Mackenzie, BS from Rutgers Robert Wood Johnson Medical School will conduct a remote project titled, “ Keeping up with Gen Z: Identifying and Validating Impactful Skincare Trends in Pediatric Dermatology ” under the mentorship of Emily Gorell, DO at University of Colorado Anschutz Medical School.
Dr. Wong, L+A Medical Contributor A leading cosmetic doctor based in London, Dr. Wong specializes in facial balancing, masculinization, and feminization using non-surgical and minimally invasive techniques.
Pelage Pharmaceuticals has closed a $16.75 We have uncovered a small molecule able to stimulate cellular metabolism to re-awaken hair follicle stem cells and spur new hair growth,” says William Lowry, PhD, scientific co-founder, Pelage Pharmaceuticals, in a news release. In addition to her clinical expertise, Dr. .
Medicaid and Medicare patient populations,” says Ted White, President and Chief Executive Officer of Verrica Pharmaceuticals, in a news release. “In J-codes are a type of HCPCS Level II code commonly used to designate non-orally administered drugs and other medical devices.
In 2023, dermatologists and their patients welcomed new drugs for acne, psoriasis, alopecia areata, and more, and 2024 promises to deliver real-world data on these medications along with even more therapeutic innovations across the spectrum of cutaneous diseases. We will, for sure, have new medications for chronic urticaria.”
Dupilumab (Dupixent, Sanofi, and Regeneron Pharmaceuticals), Lebrikizumab (Ebglyss, Almirall), and tralokinumab-ldrm (Adbry, Leo) were generally of intermediate effectiveness and among the safest but modestly increased the frequency of conjunctivitis. some of the biologics).
Children and young adults with eczema or allergies or who have difficulty swallowing may have eosinophilic esophagitis, according to a review study in the Canadian Medical Association Journal (CMAJ). Food and Drug Administration has expanded the indication for dupilumab (Dupixent, Sanofi, Regeneron Pharmaceuticals, Inc.)
featured the pharmaceutical industry. The researchers didn’t analyze gaps in education or melanoma information, but they noted that informational videos directed toward healthcare professionals often used medical terminology that the general population may find difficult. In all, 28.7% featured the perspectives of patients; 11.7%
Thus, garlic seems safer clinically and as effective as the heavy metal toxicity medication, d-penicillamine. Currently, there is no established pharmaceutical treatment for NAFLD, and dietary modifications are considered a primary approach to managing the disease. per cent efficacy: Study
Verrica Pharmaceuticals Inc. has entered into an amendment to its existing licensing agreement with Torii Pharmaceutical Co. FDA and Japan’s Pharmaceuticals and Medical Device Agency (PMDA) on the proposed design of the Phase 3 clinical trial. With a prevalence of approximately 22 million patients in the U.S.
Most medical schools still only teach how to identify late-stage autoimmune disease, not how to identify autoimmunity in its early stages and nor how to affect its progression through dietary, nutritional, pharmaceutical, or lifestyle applications. About the Author: Datis Kharrazian, Ph.D.,
Zelsuvmi is expected to be commercially available during the second half of 2024, according to Ligand Pharmaceuticals. Approved in 2023 Verrica Pharmaceuticals’ Ycanth (cantharidin) was the first U.S.-approved approved treatment for this infection, but, unlike Zelsuvmi, it requires medical supervision during application.
But today, what scares oncologists is the shortage of highly effective medications. Most people don’t realize that over 80 percent of pediatric cancers are curable,” Dr. Sarah Leary, an attending physician and medical director of the Pediatric Brain Tumor Program at Seattle Children’s Hospital, told The Epoch Times. operating sites.
There’s a crucial difference between cosmetic retinol use and medical treatment with retinoids ; the latter is for specific skin conditions under professional supervision. These medical-grade retinoids are often available only by prescription and are used under the close supervision of a healthcare provider.
Lio, MD, a Clinical Assistant Professor of Dermatology and Pediatrics at Northwestern University Feinberg School of Medicine and a partner at Medical Dermatology Associates of Chicago, discusses which ones works best. Just because they are little doesn’t mean we should be afraid to treat them and make their skin disease better,” she stresses.
better known as Weight Watchers — which bought a telemedicine firm that prescribes obesity medications earlier this year, soared 13%. Novo traded at fresh highs as the Danish pharmaceutical company gained ground on the only European megacap that is larger than it. Viking Therapeutics Inc., And WW International Inc. respectively.
Osmosis uses a unique combination of active ingredients that focuses on three important factors: our pharmaceutical-grade delivery system, because most aging occurs deep within the skin; our patented products that create real changes in the skin; and our unique inside-out approach that triggers collagen/elastin and plumps the volume of the face.
Botox and dermal fillers are powerful treatments for a wide range of aesthetic and medical conditions, but they require precise application from skilled and certified professionals. Licensed medical professionals can only purchase this controlled substance through pharmaceutical supply chains. Can Aestheticians Administer Botox?
Botox and dermal fillers are powerful treatments for a wide range of aesthetic and medical conditions, but they require precise application from skilled and certified professionals. Licensed medical professionals can only purchase this controlled substance through pharmaceutical supply chains. Can Aestheticians Administer Botox?
Disclaimer: We in no way endorse the Joe Tippens Cancer Protocol as a cure for cancer, and as always, you should consult your physician before starting any new medications or treatment plans. Click here to buy medical-grade CBD Oil >> (use code RETHN2 for a 20% discount!) What Is Fenbendazole? Is fenbendazole toxic for the liver?
Food and Drug Administration (FDA) and the Pharmaceuticals and Medical Devices Agency in Japan. Regulatory applications for the 320mg bimekizumab in a volume of 2mL device are currently in review with the U.S. The post European Commission Approves 320mg Syringes and Pens of UCB’s Bimekizumab appeared first on The Dermatology Digest.
Currently there are three main categories of pharmaceutical agents used to treat or prevent ischemia issues: thrombolytics, antiplatelets, and anticoagulants. Is there not a safer and also effective natural option for helping patients besides the above categories of pharmaceuticals? 12 Coronary Artery Disease.
Verrica Pharmaceuticals Files Lawsuit Against Canadian Drug Manufacturer for False Advertising, Unfair Competition Verrica Pharmaceuticals Inc. In addition, throughout 2024, Sanofi intends to implement coverage of miscellaneous non-medical expenses.
The increasing popularity of weight loss medications like semaglutide and tirzepatide highlights the effectiveness of GLP-1 receptor agonists in helping individuals manage their weight. In clinical trials, medications like semaglutide have shown substantial results. However, as with any medication, there are potential side effects.
Not only is this condition curable, but you aren’t restricted to opioids or other pharmaceutical treatments. Not only are trigger point massages an effective treatment plan, but they also allow you to forgo pain medication and avoid expensive and potentially risky surgical interventions.
Sun Pharmaceutical Industries, Inc. The parents misunderstand this unfamiliar word as inappropriate for family dinner conversation but quickly learn from Dr. Lee that it is a medical term that does not need to be censored. “We are thrilled to continue our collaboration with Dr. Sandra Lee, whose persona as ‘Dr.
However, medications that are already authorized are just a small percentage of what's been studied. Many researchers are still trying to find and develop other medications that can treat or prevent COVID-19. The product is authorized as a medical device targeting COVID-19 in India, Israel, Bahrain, Indonesia and Thailand.
LEO Pharma recently acquired TMB-001 and other assets from Timber Pharmaceuticals following Timber’s Chapter 11 bankruptcy filing. Mr. Hilberdink: “LEO Pharma is a company that truly aspires to be a leading medical dermatology company that looks at unmet needs in the marketplace, and we see an unmet need in congenital ichthyosis (CI).
Recent studies indicate that dry, itchy scalp is a significant global issue, with about 40% of the world’s population seeking medical help for symptoms related to scalp dryness. [1] Medicated Shampoos : Those containing coal tar and salicylic acid are effective for psoriasis, aiding in scaling and inflammation reduction.
Lio, MD, a Clinical Assistant Professor of Dermatology and Pediatrics at Northwestern University Feinberg School of Medicine and a partner at Medical Dermatology Associates of Chicago, discusses which ones works best. Just because they are little doesn’t mean we should be afraid to treat them and make their skin disease better,” she stresses.
Verrica Pharmaceuticals Inc.’s The Company also plans to submit the final Phase 2 data for presentation at future medical meetings. s VP-315 is showing promise in the treatment of basal cell carcinoma, according to Part 2 of its Phase 2 clinical trial.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content